Safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD™ vaccination over 24 weeks: a multicentre randomized double-blind placebo-controlled trial

IntroductionAshwagandha (Withania somnifera Dunal) is an Ayurveda medicine that was widely used during the COVID-19 pandemic. In the context of widespread use of herbal formulations alongside COVID-19 vaccination, this study evaluated the safety, tolerability, and exploratory immunological outcomes...

Cijeli opis

Bibliografski detalji

Glavni autori:	Arvind Chopra, Susmita Chaudhuri, Manohar S. Gundeti, S. Sarmukaddam, Girish Tillu, Preeti Chavan-Gautam, Shruti Khanduri, Sophia Jameela, Azeem Ahmad, Amit Kumar Rai, Prasanna N. Rao, Sarvesh Kumar Singh, Santosh Y. Mudakappagol, Govind Reddy, Tanuja Nesari, Dilip Gode, K. Rajeshwar Reddy, Manjit Saluja, Sanjay Tamoli, Dattatray Dighe, B. C. Ravikumar, B. G. Vittal, Shailaja U., Rakesh, M. S. Seetharamu, Kshipra Rajoria, Giridhar Vedantam, Shashikant Dudhgaonkar, Rasika Kolhe, Swapnil Borse, U. R. Sekhar Namburi, Manish P. Deshmukh, Priyanka Bangre, Anand More, S. Rajgopala, Raju Singh, Shalini Rai, Sandeep Singh Tiwari, Sanket Jain, Amrish P. Dedge, Babita Yadav, BCS Rao, N. Srikanth, R. N. Acharya, Bhushan Patwardhan
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-08-01
Serija:	Frontiers in Medicine
Teme:	Ayurveda COVID-19 vaccine herbal medicine immunogenicity safety withaniasomnifera
Online pristup:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1852954/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!